Proteome Sciences plc claimed it would be the first to commercialize a product based on proteomics when it announced a deal to use its protein biomarkers for stroke in point-of-care diagnostic equipment. (Bioworld International)

Proteome Sciences plc claimed it would be the first to commercialize a product based on proteomics when it announced a deal to use its protein biomarkers for stroke in point-of-care diagnostic equipment. (Bioworld International)

LONDON - Peace has broken out in long-running wars over antibody phage display patents, with Cambridge Antibody Technology Group plc granting licenses to MorphoSys AG and Crucell NV, and all existing litigation between the companies being withdrawn.(BioWorld International)